Excelsior Medical Co., Ltd. · TWSE:4104
Excelsior Medical — H1 2019 Earnings Presentation
33 slides from Excelsior Medical's earnings presentation, 2019
Slide 1: Excelsior Medical Co., Ltd. 2019 H1 Investor Conference
Excelsior Medical Co., Ltd. 2019 H1 Investor Conference
Slide 2: Disclaimer
Disclaimer This presentation is prepared according to the reviewed financial statements by CPA and the financial figures hereby are based on IFRS, please refer to the published financial statements for full content. The presentation may contain forward-looking information and may differ materially f
Slide 3: Table of Contents
Table of Contents 1.公司概況(Corporate Overview) P.4 2.市場概況(Market Overview) P.8 3.營運概況(Business Overview) P.11 4.財務概況(Financial Overview) P.14 5.轉投資概況(Investment Overview) P.17 6.2019策略及展望(2019 Strategies and Outlook) P.23 7.補充資料(Appendix) P.26 3
Slide 4: Corporate Overview
Corporate Overview Chairman Group President Tony Fu “Dedication, Discipline, Innovation, Proactive” are the core values of Excelsior . “Human Healthcare” is the basis of medical service industry. Therefore, “Dedication” to our service target is what matters the most. We focus on public healthcare, u
Slide 5: The Most Valuable Total Healthcare Solution Provider among Asia
The Most Valuable Total Healthcare Solution Provider Teams！ among Asia with Exceptional Investment and Operating Teams！ Excelsior Medical Co.,Ltd Co.,Ltd.. was founded in 1988，Excelsior started with the distribution of hemodialysis equipments and supplies . Gradually transformed into medical service
Slide 6: Revenue structure
Revenue structure Excelsior yearly consolidated sales is more than NT $ 6 billion, the primary revenue comes from Excelsior(Hemodialysis), Dynamic(Medical Aesthetic), Arich (Pharmaceutical Logistics) and others. According to the company’s function ,the business type can be characterized as trading b
Slide 7: The Business Types
The Business Types Hemodialysis Medical Aesthetic Trading Business Medical Equipment Medical Consumables Home Appliance Product Planning Sales Information Analysis Promotion Hemodialysis channel Medical Information System Market Creative Medical Aesthetic channel Pharmaceutical Distribution Manageme
Slide 8: Market Overview: Excelsior (Hemodialysis)
Market Overview Excelsior(Hemodialysis Excelsior(Hemodialysis)) Taiwan benefited from the implementation of the national health insurance system in 1995 and the hemodialysis technology and quality gradually mature, the patient's survival rate has gradually increased. According to National Kidney Fou
Slide 9: Dynamic (Medical Aesthetic)
Dynamic(Medical Aesthetic) According to the Asian-Pacific Market Study issued by Medical Insight, Inc. in Jan. 2019, total Asian sales of all aesthetic products and equipment reached USD $2.1 billion in 2017 and are expected to increase by 13.2% per year through 2022. Furthermore, medical aesthetic
Slide 10: Arich (Pharmaceutical Logistics)
Arich (Pharmaceutical Logistics) Pharmaceuticals cost approximately 1/4 of National Health Insurance expenditures. In Taiwan, although demand for medication is growing, but the prices approved/reimbursed by NHI are declining. Consequently the multinational pharmaceutical companies keep on outsourcin
Slide 11: Business Overview: Excelsior (Hemodialysis)
Business Overview Excelsior(H Excelsior(Hemodialysis emodialysis)) Excelsior operating incomes were NT $ Units: NTD in thousands 267,803 (NTD in thousands) in 2017 and NT $ 3,561,288 3,733,339 6% 279,606 (NTD in thousands) in 2018; the 6% growth rate was 4.4%。 The greater operating 34% income in 201
Slide 12: Dynamic (Medical Aesthetic)
Dynamic(Medical Aesthetic) Units: NTD in thousands Dynamic operating income were $ 133,005 (NTD in thousands) in 2018 and $ 194,093 (NTD in thousands) in 2017, due to the decreasing 16% 13% gross margin which was a result of inventory valuation. 54% 54% Operating Income of 2019 H1 is more than 13% w
Slide 13: Arich (pharmaceutical logistics)
Arich (pharmaceutical logistics) Units: NTD in thousands Arich operating income were NT$ 46,410 thousand dollars in 2018 and NT$ 2,739 thousand dollars in 2017, because it was a transitional period of adjusting customers 22% 21% portfolio and revenues composition. Operating income of 2019 H1 is more
Slide 14: Financial Overview
Financial Overview Consolidated sales Consolidated gross profit Units: NTD in thousands Units: NTD in thousands Consolidated operating income Units: NTD in thousands 14
Slide 15: Units: NTD in thousands Units: NTD in thousands
Units: NTD in thousands Units: NTD in thousands 15
Slide 16: Units: NTD in thousands Units : NTD in Dollars
Units: NTD in thousands Units : NTD in Dollars 16
Slide 17: Investment Overview
Investment Overview Hemodialysis channel – Excelsior Renal Service Co., Limited &Jiate Excelsior Co., Ltd 【 Hemodialysis channel Introduction 】 Excelsior entered into a joint venture with Fresenius which is the world's largest manufacturer of dialysis products, and establishes long-term cooperative
Slide 18: Hemodialysis channel – Excelsior Renal Service Co., Limited & Jiate Excelsior
Hemodialysis channel – Excelsior Renal Service Co., Limited &Jiate Excelsior Co., Ltd Units : except ERS channels， NTD in thousands 18
Slide 19: Hemodialysis channels
Total % Area ERS channels channels Taipei：19 keelong：3 North 252 34 13.5% Central 195 43 22.1% South 190 24 12.6% other 37 1 2.7% Total 674 102 15.1% Taoyuan：8 Hsinchu：2 Miaoli：2 Taichung：28 Changhua：7 Yilan ：1 Yunlin：2 Nantou：6 Chiayi：4 Tainan：9 pingtung：4 Kaohsiung：7 Hemodialysis channels 19
Slide 20: Long-Term Care Channels – Asia Best Healthcare Co., Ltd.
Long-Term Care Channels– Asia Best Healthcare Co., Ltd. Xi--zhi Nursing Home Xi 內部配置 【 Long-Term Care Channels Introduction 】 Excelsior combines the experiences and advantages in medical industry, with innovative concepts to build higher service standards of long-term care channels. We provide Long
Slide 21: Long-Term Care Channels – Asia Best Healthcare Co., Ltd.
Long-Term Care Channels– Asia Best Healthcare Co., Ltd. Units:except ABH Beds， NTD in thousands 招大廳 21
Slide 22: Long-term care channels
Hospital/long-term care Hospital Beds 525 Long-term care channels Long-term care 2,633 Total 3,158 keelong：114 beds Xizhi Taoyuan : 204 beds Taipei：165 beds Ping- zhen New Taipei City： 1,275 beds Taichung：591 beds Tai -chung Changhua: 200 beds Yunlin ：131 beds Kaoh -siung Nantou ：294 beds Kaohsiung
Slide 23: 2019 Strategies and Outlook
2019 Strategies and Outlook Excelsior(Hemodialysis Excelsior(Hemodialysis)) Long-Term Planning Mid-Term Planning Excelsior develops from Taiwan to Asia , and follows government’s direction “The 1.Integrating upstream and New Southbound Policy ”, we downstream medical resources , will proceed to focu
Slide 24: Dynamic (Medical Aesthetic)
Dynamic(Medical Aesthetic) Long-Term Planning Being a product leader in Mid-Term Planning the medical cosmetology Hya-Dermis market All-round one-stop As a market leader, beauty therapy service continue to lead Leading -EB the market for beauty Short-Term Plan -Dr. CYJ HCC Medytox_Neuronox
Slide 25: Arich (pharmaceutical logistics)
Arich (pharmaceutical logistics) Long-Term Planning 1.Sales Revenue Mid-Term Planning A.To seek strategic partners and to expand the variety of our 1.Sales Revenue products. A.Medication：To increase B.To integrate excelsior group’s our product items. dialysis and long term care B.Dementia medication
Slide 26: Appendix: Balance Sheet Assets
Appendix Units: In thousands NTD 2017.12.31 2018.12.31 2019.06.30 Assets Current Assets Cash and Cash Equivalents 2,473,892 3,100,081 3,203,076 Receivables 2,199,672 1,605,261 1,576,143 Other Receivables 3,562,727 3,765,675 3,852,911 Inventories 1,121,982 1,008,284 907,654 Other Current Assets 1,172
Slide 27: Liabilities and Equity
Units: In thousands NTD 2017.12.31 2018.12.31 2019.06.30 Liabilities Current Liabilities Short-Term Loan 1,160,000 1,110,000 1,030,000 Payables 1,029,336 1,014,679 990,338 Other Payables 3,262,492 2,498,680 2,988,739 Other Liabilities 954,248 482,617 523,626 Total Current Liabilities 6,406,076 5,105
Slide 28: Statement of Comprehensive Income
Statement of Comprehensive Income Units: In thousands NTD 2017 2018 2019 H1 Operating Revenue 6,095,337 6,345,031 3,144,499 Operating Costs 4,889,039 5,145,866 2,506,735 Gross Profit 1,206,298 1,199,165 637,764 Gross Margin 19.79% 18.90% 20.28% Operating Expense 753,736 761,046 374,780 Operating Inc
Slide 29: Cash flows from operating activities
Units: In thousands NTD 2017 2018 2019 H1 Profit before income tax 554,237 648,500 392,129 Adjustments items (60,595) (92,888) (41,021) Cash flows from operating Activities Receivable (increase) decrease (106,519) 190,288 31,001 Other Receivable decrease 1,244,175 182,201 53,696 Inventories (increas
Slide 30: Cash flows from investing activities
Units: In thousands NTD 2017 2018 2019 H1 Cash flows from investing activities Purchase of financial assets at amortized cost - (1,027,056) (329,798) Proceeds from disposal of financial assets at - 1,716,236 60,000 amortized cost Purchase of debt investments with no active (715,670) - - market Proce
Slide 31: Cash flows from financing activities
Units: In thousands NTD 2017 2018 2019 H1 Cash flows from financing Activities Increase (decrease) in short-term loans 255,000 (50,000) (80,000) Repayments of bonds - (300,000) - Repayments of long-term loans (9,920) - - Dividends paid to owners of the Company (319,067) (357,917) - Partial acquisiti
Slide 32: Growing up with Long-term partners
Growing up with Long- Long-term partners Excelsior has been operating for 30 years, accumulated core competitiveness with new ideas created, new models to integrate variously professional medical fields. Excelsior will keep take root in the Asia market, the business scope includes Taiwan, Hong Kong,
Slide 33: Growing up with Long-term partners
Growing up with Long- Long-term partners Excelsior has been operating for 30 years, accumulated core competitiveness with new ideas created, new models to integrate variously professional medical fields. Excelsior will keep take root in the Asia market, the business scope includes Taiwan, Hong Kong,